Patents by Inventor Daniel Christ

Daniel Christ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240043506
    Abstract: The present disclosure is directed to isolated or recombinant antigen binding proteins, such as antibodies, which bind to coronavirus spike (S) protein receptor binding domain (RBD), including S protein RBD from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present disclosure is also directed to the use of the isolated or recombinant proteins as therapeutic, prophylactic and/or diagnostic agents for respiratory conditions associated with coronavirus infection, such as infection by SARS-CoV-2. The present disclosure is also related to nucleic acid sequences which encode said antigen binding proteins and their expression in recombinant host cells.
    Type: Application
    Filed: December 23, 2021
    Publication date: February 8, 2024
    Inventors: Ohan MAZIGI, David LANGLEY, Peter SCHOFIELD, Daniel CHRIST
  • Patent number: 11332522
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: May 17, 2022
    Assignee: GARVAN INSTITUTE OF MEDICAL RESEARCH
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Publication number: 20210047428
    Abstract: The present disclosure relates to methods of generating antibodies with improved specificity and/or affinity for a target antigen, as well as B-cells and hybridomas expressing the antibodies and compositions comprising antibodies with improved specificity and/or affinity for the target antigen.
    Type: Application
    Filed: March 29, 2019
    Publication date: February 18, 2021
    Applicant: Garvan Institute of Medical Research
    Inventors: Daniel CHRIST, Robert BRINK, Christopher GOODNOW, Deborah BURNETT, Peter SCHOFIELD
  • Publication number: 20200102376
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: May 9, 2019
    Publication date: April 2, 2020
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Publication number: 20200033363
    Abstract: The present disclosure generally relates to proteins containing immunoglobulin light chain variable region homodimers, to methods of providing such proteins and to various uses of such proteins. In one example, the disclosure provides a method for screening a plurality of immunoglobulin homodimers, each homodimer comprising two identical light chain variable domain monomers, wherein screening of the immunoglobulin homodimers comprises identifying homodimers that are capable of binding specifically to an antigen to form an immunoglobulin-antigen complex.
    Type: Application
    Filed: March 27, 2018
    Publication date: January 30, 2020
    Inventors: Daniel CHRIST, Mary CHRISTIE
  • Publication number: 20170240619
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: November 7, 2016
    Publication date: August 24, 2017
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Patent number: 9527908
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: December 27, 2016
    Assignee: GARVAN INSTITUTE OF MEDICAL RESEARCH
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Publication number: 20160145328
    Abstract: The present disclosure provides an isolated protein comprising an antibody heavy chain variable region (VH) comprising a negatively charged amino acid at position 28 and/or 31 and/or 32 and/or 33 and/or 35 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: October 21, 2015
    Publication date: May 26, 2016
    Inventors: Daniel Christ, Kip Dudgeon
  • Patent number: 9291540
    Abstract: The invention relates to a device for detecting the abrasive wear on components of water turbines, having a wearing body, and a measuring unit for detecting the wear on the wearing body. The invention is characterized in that the wearing body is arranged in the flow flowing through the water turbine, the wearing body is implemented as a sonotrode and is connected to an ultrasound generator, and the measuring unit is implemented to measure the resonant frequency of the sonotrode.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: March 22, 2016
    Assignee: Voith Patent GmbH
    Inventors: Axel Kratzsch, Daniel Christ, Jan Schoppa
  • Publication number: 20150307599
    Abstract: The present disclosure provides proteins comprising antibody variable regions that bind specifically to NPY and PYY and uses thereof and methods of treating or preventing cancer or inducing an immune response by inhibiting NPY and PYY.
    Type: Application
    Filed: December 3, 2012
    Publication date: October 29, 2015
    Inventors: Martijn Bijker, Herbert Herzog, Fabienne McKay, Romain Rouet, Peter Schofield, David Zahra, Daniel Christ
  • Publication number: 20140234218
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: October 15, 2013
    Publication date: August 21, 2014
    Applicant: GARVAN INSTITUTE OF MEDICAL RESEARCH
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Publication number: 20140102199
    Abstract: The invention relates to a device for detecting the abrasive wear on components of water turbines, having a wearing body, and a measuring unit for detecting the wear on the wearing body. The invention is characterized in that the wearing body is arranged in the flow flowing through the water turbine, the wearing body is implemented as a sonotrode and is connected to an ultrasound generator, and the measuring unit is implemented to measure the resonant frequency of the sonotrode.
    Type: Application
    Filed: January 7, 2013
    Publication date: April 17, 2014
    Inventors: Axel Kratzsch, Daniel Christ, Jan Schoppa
  • Publication number: 20120207673
    Abstract: The present disclosure provides an isolated protein comprising an antibody heavy chain variable region (VH) comprising a negatively charged amino acid at position 28 and/or 31 and/or 32 and/or 33 and/or 35 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: October 25, 2010
    Publication date: August 16, 2012
    Inventors: Daniel Christ, Kip Dudgeon